| 1. | 387368dman | |
| 2. | kitcaitrn | |
| 3. | jeepmagick | |
| 4. | jil4411 | |
| 5. | matthewsmelt6 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | jeepmagick 06/18/2018 Good reason to feel good. |
| 2. | 387368dman 02/12/2018 Cantor Fitzgerald raises price target to $5 from $2 |
| 3. | kitcaitrn 02/09/2018 Misses EPS loss estimates by $0.02 and misses on revenues |
| 4. | 387368dman 02/22/2018 Receives regulatory clearance to begin Phase 1 Study of ARO-AAT for treatment of Alpha-1 Liver disease |
| 5. | jil4411 06/29/2018 Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference |
| 6. | matthewsmelt6 03/27/2018 Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B |
| 7. | jeepmagick 02/15/2018 Receives regulatory clearance to begin Phase 1/2 study of ARO=HBV for treatment of Hepatitis B |
| 8. | 387368dman 05/21/2018 Presents new data on ARO-ENaC |
| 9. | kitcaitrn 02/15/2018 Granted orphan drug designation |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Arrowhead Pharmaceuticals, Inc.
- ARWR
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.